Precision health,
engineered from the ground up.
We study the problems that arise across the precision health pipeline — from the biosensors that screen for disease, to the models that stratify risk, to the systems that deploy at the point of care.
Our Research Pipeline
How we think about precision health.
Our work spans three interconnected domains — each representing a stage in the journey from biological signal to clinical impact.
Catching disease at its earliest signal
Engineering the sensing and diagnostic systems that detect disease before symptoms appear.
Predicting who needs what treatment, and when
Translating multimodal data into individualized risk profiles and treatment strategies.
From validated model to standard of care
Building the infrastructure that moves precision medicine from the lab into routine clinical practice.
Active Research
What we're working on.
Current research projects across our pipeline — from biomarker discovery to clinical AI evaluation.
Mitochondrial DNA Variants & Weight Loss Interventions
Investigating mitochondrial DNA variants as a predictive biomarker for the effectiveness of weight loss interventions — toward genotype-informed treatment selection.
Precision Screening for Colorectal Cancer
Developing a precision screening framework for colorectal cancer that integrates risk stratification with optimized screening protocols.
LLM Evaluation in Healthcare Encounters
Evaluating how patients interact with large language models for health information and exploring the downstream effects on clinical encounters and shared decision-making.
VOC Biomarkers for Early Disease Detection
Exploring volatile organic compounds as non-invasive biomarkers for predicting early signs of disease, with a current focus on colorectal cancer.
Metasurface Biosensing for Minimally Invasive Screening
Developing metasurface-based biosensing architectures as an approach for high-sensitivity, minimally invasive disease screening.